Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor

NCT02639650 · clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
214
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Weiguo Lv

Collaborators